ASSOCIAÇÃO ENTRE O NÍVEL DE CAPACIDADE AERÓBICA E DIAGNÓSTICO DE DEMENCIA

Dement Neuropsychol dn Dementia & Neuropsychologia Dement. neuropsychol. 1980-5764 1980-5764 Associação de Neurologia Cognitiva e do Comportamento RESUMO. A capacidade aeróbica diminui significativamente ao longo da vida, começando com a idade de 30 anos e acelerando a partir dos 60 anos, onde se prevê um declínio de 17% por década. Objetivo: Investigar a associação entre a capacidade aeróbica medida e o risco de desenvolvimento de comprometimento cognitivo leve (CCL), DA leve e moderado em idosos, considerando as classificações de risco de perda funcional para o teste do STEP. Métodos: Nesse estudo de corte-transversal, foram avaliados 93 idosos (>60 anos) (saudáveis=36; CCL=18, DA=39). Para acessar a capacidade aeróbica foi utilizado o teste de STEP e o estado cognitivo global foi medido através do MEEM. Os grupos foram divididos em relação às classificações de risco de perda funcional em abaixo ou acima do ponto de corte padronizado para idosos. Resultados: Idosos incluídos no grupo de risco de perda funcional tinham aproximadamente dez a catorze vezes mais chances de serem diagnosticados com DA leve (O.R:10.7; p=0.001) e moderado (O.R.=14.7; p=0.002), do que os seus pares mais bem condicionados. Menores níveis de capacidade aeróbica também foram associados com o diagnostico de CCL (O.R=4.5; p=0.05), entretanto apenas após controle por idade, escolaridade e sexo. Na amostra total (N=93) houve uma associação entre a capacidade aeróbica e o MEEM (R2=0.35; p<0.001) depois de controlado pelas variáveis confundidoras. Conclusão: Idosos que se encontram dentro da classificação de risco de perda funcional medida através do teste de STEP possuem maiores chances de desenvolverem CCL, Alzheimer leve e moderado mesmo após controle por idade, sexo e escolaridade. Aerobic capacity declines significantly throughout life, beginning at the age of 30 years and accelerating from 60 years, where a decline of 17% per decade is expected thereafter.1 It is believed that this decrease may intensify the process of aging and functional decline, contributing to greater dependence of elderly, through the impairment of their basic and instrumental (IADL) activities of daily living (ADLs).2 The maintenance of aerobic capacity during aging is also associated with a lower incidence of cardiovascular and metabolic diseases, preservation of cognitive performance3,4 and lower risk of dementia, such as dementia due to Alzheimer’s disease (AD).5 Since AD is a neurodegenerative disease and still has no cure, public health strategies have been focused on prevention and better clinical responses, such as preservation of cognitive ability and ADLs. The identification of cognitive decline and loss of functioning allows the implementation of early interventions and treatments, reducing the costs of disease and improving quality of life of patients.6 Considered an intermediate stage between healthy aging and dementia, mild cognitive impairment (MCI) represents a transitional phase in which patients present memory and/or executive function deficits, as well as reduced volume of brain structures common to AD.7 However, unlike individuals with Alzheimer’s, their independence for ADLs is still preserved.8 It is speculated that the rate of conversion from MCI to AD lies between 20 and 40%, being 10 to 15% per year.9 Lifestyle can help reduce the risk of conversion from MCI to Dementia. Recently, Müller and Chan10 demonstrated that, for every 1MET (Metabolic Equivalent of Task- approximately 3.5ml.kg-1.min-1) increase in VO2peak, there is an associated 8% decrease in risk of conversion to MCI and dementia. However, although ergospirometry was considered the “gold standard” method for obtaining the VO2 measurement, its use is limited by the high cost and need for equipment and specialists to perform the test, restricting its use to clinical environments and making it a technique of little ecological validity. An alternative is the STEP test from the Senior fitness test battery, proposed by Rikli and Jones.11 This evaluation is considered to have good reproducibility and easy applicability for assessing aerobic capacity in elderly people. In addition, its scores also allow the assessment of the risk of functional loss (RFL) of elderly related to aerobic capacity performance. Therefore, the main objective of this study was to investigate the relationship between the level of aerobic capacity and the risk of diagnosis of MCI, mild and moderate AD in older adults. As a secondary objective, the correlation between aerobic capacity and global cognitive state was analyzed. METHODS We recruited elderly (>60 years old), diagnosed with AD or MCI (according to criteria previously proposed by Petersen12) and cognitively intact, through medical staff at the Center of Alzheimer Disease of the Psychiatry Institute of the Federal University of Rio de Janeiro. Diagnostic assessment was performed by structured clinical interview SCID for assessment of mental disorders and according to the Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV). Patients were classified by the Clinical Dementia Rating (CDR): 0.5-1.0 (mild) 2.0 (moderate) and 3.0 (severe). The exclusion criteria for AD were: cerebral infarction; ongoing treatments such as electroconvulsive therapy and psychotherapy; any other presenting neurological disorders; as well as diagnosis of other types of dementia; and the presence of any physical disability that rendered the individual unable to perform assessments; and severe visual and/or hearing impairment. The exclusion criteria for healthy subjects were the presence of any physical disability that rendered the individual unable to perform assessments; the presence of neurological or mental disorders, and severe visual and/or hearing impairment. All patients signed the written informed consent form. This study was approved by the Research Ethics Committee of the IPUB-UFRJ, under registration permit CAAE:24904814.0.0000.5263 and was part of a larger research project entitled, “Efficacy of physical exercise in the treatment of Major Depression, Alzheimer’s Disease and Parkinson’s Disease”. Procedures and tests The assessments were made in three visits. On the first day, participants signed the written informed consent form, underwent anthropometric measurements, completed an anamnesis, as well as the International Physical Activity Questionnaire (IPAQ-short version), Lawton Scale and MMSE. The second visit entailed a maximal treadmill test to predict VO2max and to assess possible cardiac health problems. The STEP test was performed on the third visit. Step test The 2-minute Step test is an easy-to-use approach for assessing aerobic capacity of older adults.11 A mark is made on a wall or door with tape at a height midway between the subject’s patella and iliac crest. After the signal “go”, the participant must alternate steps on the spot for the scheduled time period. The score is the number of times the right knee reaches the required height in 2 minutes and the cut-off point for risk of functional loss is 65 steps. VO2 protocol The test consisted of a ramp protocol and a treadmill InbraMed Pro* was used.13 A fixed ramp protocol was used with determination of initial and final velocities and inclination. The increase in workload was progressive and continuous with gradual increments of velocity and/or inclination every 30 seconds. The assessment was programmed for patients to reach an estimated VO2max in 10 minutes, followed by a 6-minute recovery. A 12-lead Digital ECG electrocardiograph (MICROMED®) was used for monitoring and recording blood pressure and heart activity. Estimated VO2 was obtained using the following equation: VO2(ml/Kg/min) = velocity × [0.1+ (inclination/100 x 1.8)] + 3.5.13 Statistical analysis Normality and homoscedasticity of the sample were analyzed by Kolmogorov-Smirnov and Levene tests. Comparative analyzes were performed separating the groups by diagnosis (healthy, MCI, mild and moderate AD) and risk of functional loss (<65 Steps) using one-way ANOVA and the Kruskall-Wallis test according to the criteria of normality. To determine differences among groups, Bonferroni post hoc and Mann-Whitney tests were applied. An association between performance on the STEP test and on the MMSE was investigated using Spearman correlations for non-parametric data. The Chi-square analysis test was used to compare categorical variables. Associations between aerobic capacity and diagnosis were explored by multiple regression (hierarchical and stepwise) and logistic models. Statistical analysis was conducted using SPSS® software version 20.0 (IBM Corporation, New York, USA). The level of significance was p≤0.05 RESULTS Of the 119 participants initially recruited, 9 elders were excluded because they did not meet the study inclusion criteria, 15 participants had no interest in continuing the research and 2 dropped out due to unavailability of the caregiver (Figure 1). Thus, the final sample consisted of 93 participants, comprising 36 healthy elderly, 18 patients diagnosed with MCI, 25 with mild AD and 14 with moderate AD. Thirty-three elders (35.9%) were classified as having risk of functional loss on the STEP test (Healthy=14.3%, MCI=33.3%, mild AD=57.1%, moderate AD=56%). There were significant differences in age (p<0.02) and educational levels (p<0.02) among the groups. Also, groups varied significantly for sex, where the majority of the study sample was female (p=0.03). The AD group was physically more classified as being at risk of functional loss, with mean STEP values of 63.8±27.2 reps (mild AD) and 54.6±26.5 reps (moderate AD), while means of healthy and MCI groups were 87.6±20.8 and 75.7±21.0 reps, respectively. These results were also observed for IADL evaluated by the Lawton Scale, which showed that the AD group was more dependent than the others. However, the groups did not differ in total physical activity levels, as measured by the IPAQ-MET (p=0.06 effect size=0.2). A significant difference was observed among the groups for cognitive performance measured by the MMSE (p≤0.001), showing that AD patients were more impaired than other participants. However, a Mann-Whitney analysis demonstrated no difference in overall cognitive state between healthy elderly and MCI subjects (p=0.40). After controlling for confounding variables, aerobic capacity (measured by STEP test) was found to be significantly associated with global cognition (R2=0.35 p<0.001), while VO2 max had a significant contribution to diagnosed condition (R2=0.19 p<0.001). Descriptive data of the sample is presented in Table 1. In addition, results of the multiple linear regression revealed that diagnoses can explain the decline in aerobic capacity evaluated by STEP, after controlling for age, sex and educational level (R2=0.45 p<0.001). Diagnosis alone represented 22% of the prediction of functional capacity (Table 2). Moreover, subjects in the functional loss risk group were approximately ten to fourteen times more likely to be diagnosed with mild (OR:10.7; p=0.001) or moderate (OR.=14.7; p=0.002) AD than their fitter counterparts (Table 3). Figure 1 Flow chart of subject selection process. Table 1 Descriptive analyses of the samples. Healthy(n=36) MCI(n=18) Mild AD(n=25) Moderate AD(n=14) χ2/F p Age (years) 74.2±9.2 78.0±5.5 78.5±7.4 78.9±8.3 2.041a 0.02 Education (years) 12 (1-29) 15 (3-18) 11 (2-23) 12 (1-16) 6.025b 0.02 Sex (% of total cohort) Female 30 (31.9%) 10 (11%) 16 (17.6%) 6 (6.6%) 8.743b 0.03 Male 6 (6.6%) 8 (8.8%) 9 (8.8%) 8 (8.8%) Medication (n) 2 (0-9) 1 (0-7) 5 (1-11) 2.5 (1-9) 14.731b 0.002**++ Chronic diseases (n) 0.5 (1-3) 1 (1-3) 2 (1-6) 0.5 (1-3) 14.398b 0.002**++ Cardiovascular disease (n) 0 (0-1) 0.5 (0-2) 0 (0-2) 0 (0-1) 7.502b 0.05 ||** BMI (kg/m2) 25.8 (20.9-34.0) 25.1 (22.0-32.2) 24.9 (18.7-38.2) 25.6 (18.6-28.9) 0.437b 0.93 VO2max (mL . kg-1.min-1) 22.2±6.2 21.1±4.7 18.2±4.6 17.7±6.5 3.626a 0.01** STEP test (score) 87.6±20.8 75.7±21.0 63.8±27.2 54.6±26.5 8.553a <0.001* IPAQ (METs/week) 883.5 (33-12.558) 1221.7 (50-6.384) 462 (66-6.132) 772.5 (132-1.448) 7.382b 0.06 Lawton (score) 21 (6-27) 20 (11-21) 13 (8-18) 10 (7-17) 59.286b <0.001*+ MMSE (score) 29 (21-30) 29 (19-30) 21 (13-28) 15 (5-22) 59.040b <0.001*+ BMI: body mass index; MET: metabolic equivalent; MMSE: Mini-Mental State Examination; mean ± standard deviation; Median (minimum - maximum); χ2: chi-squared. a one-way ANOVA; b Kruskall-Wallis Test; * Significant difference among Healthy, mild AD and moderate AD; ** Significant difference between Healthy and mild AD; || Significant difference between Healthy and MCI; + Significant difference among MCI, mild AD and moderate AD; ++ Significant difference between MCI and mild AD. Level of significance: p=0.05. Table 2 Association between aerobic capacity and the different diagnoses. Model B 95% CI p R2=0.22* 1 Diagnosis -11.2 -15.6 -6.9 <0.001 R2= 0.45* 2 Age -0.5 -1.1 -0.04 0.03 Sex 22.6 13.4 31.8 <0.001 Education 0.6 -0.1 1.4 0.09 Diagnosis -12.0 -16.0 -8.0 <0.001 B: unstandardized coefficients. CI: confidence interval. * level of significance: p ≤0.005. Table 3 Association between Risk of Functional Loss (RFL) on STEP test and diagnosis of MCI and AD. MCI Mild AD Moderate AD OR (95% CI) p OR (95% CI) p OR (95% CI) p STEP test Without RFL Reference RFL 3.0 0.76-11.71 0.11 7.6 2.22-26.20 0.001 8.0 1.93-33.10 0.004 Without RFL* Reference RFL 4.5 0.99-21.10 0.05 10.7 2.65-43.64 0.001 14.7 2.63-82.11 0.002 OR: odds ratio; CI: confidence interval; * Adjusted for age, sex and educational level. Level of significance: p ≤0.05. DISCUSSION Aerobic capacity measured by the STEP test was positively correlated with global cognition. In addition, the performance classified as a risk for functional loss on the STEP test contributes to the increased chances of MCI and Alzheimer’s diagnosis in the mild and moderate stages of the disease. The different diagnoses explained 22% of the worsening of cardiorespiratory performance, represented by a decrease of about 11 repetitions on the STEP test. Some authors argue that this may represent a set of systemic, motor and cognitive changes that start in the pre-dementia stages and change as the disease progresses.14,15 Burns, Cronk et al.15 reported a reduction in VO2peak among individuals with AD and its correlation with brain atrophy caused by dementia, suggesting the possibility that the metabolic dysfunctions occurring in the brain of these elderly are also occurring in the muscle periphery, making AD a systemic disease. Motor changes also demonstrate a worsening dependent on disease progression, especially for motor processes regulated by complex cortical mechanisms.16,17 When separated by RFL, physically vulnerable individuals were approximately 11 times more likely to be diagnosed with AD, and almost 15 times more likely when considering the influence of risk factors such as age, educational level and sex. Previous studies have shown a positive impact of aerobic capacity on cognition in elderly, indicating that cardiorespiratory resistance may protect this group from possible cognitive dysfunctions. Barnes, Yaffe et al.18 investigated the relationship of aerobic capacity in young elderly with cognitive function for 6 years. At the end of this period, individuals whose aerobic capacity was preserved had better cognitive performance, as evaluated by the MMSE. Voss, Weng et al.19 found that modifications in the neural pattern network (responsible for executive function and selective attention) during aging are mediated by cardiorespiratory capacity. According to the authors, these results seem to be independent of the level of usual physical activity. Aerobic capacity also seems to attenuate the relationship between important genetic risk factors and AD.20,21 After controlling for sex, age and educational level, regression analyses showed that elderly classified with RFL on the STEP test also have a risk of being diagnosed with MCI. Aerobic capacity has been shown to be an important neuroprotective factor during the disease course. Teixeira, Rezende et al.22 reported a relationship between the volume of the gray matter and the integrity of the white matter with the cardiorespiratory fitness of individuals with amnestic MCI, especially in frontal areas. These results are supported by Ding, Tarumi et al.23 who verified that high levels of aerobic capacity are correlated with the preservation of white matter integrity and the executive function of elderly with MCI, even after controlling for age, sex, lesion burden and disease progression, reinforcing the hypothesis of cognitive reserve. This neuroprotective effect may be associated with the influence of aerobic capacity on the vascular system through changes in cerebrovascular conductance and blood pressure.24 Although aerobic capacity is a variable strongly influenced by genetics (50%),25 physical exercise has shown to be an effective means of increasing it. Baker, Frank et al.26 found that aerobic exercise performed 4 times a week in elderly patients with MCI for 60 min (75%-85% of reserve heart rate) for 6 months was able to significantly increase VO2max and VO2peak, as well as improve cognitive flexibility and attention. The authors found a relationship between VO2peak and executive function in the exercise group. Smith, Nielson et al.27 reported a 10% increase in the VO2peak of healthy patients and of those with MCI after 2 months with a walking intervention (50%-60% of reserve heart rate) 4 times a week, an increase followed by improvements in neural efficiency during a semantic memory test. Salisbury28 analyzed elderly with AD before and after completing 6 months of moderate aerobic training and found that each additional meter walked in the reevaluation in the shuttle walk test represented an improvement of 0.88 points on the ADAS-cog. Other studies have also demonstrated the efficacy of aerobic exercise in increasing aerobic capacity and cognition in elderly with MCI and AD,29,30 and likewise for multimodal training (aerobic, flexibility and strength).31 Strength training seems to improve aerobic capacity only in elderly whose relative VO2max is less than 25ml.kg-1.min-1.32 However, strength training, regardless of the initial aerobic capacity, promotes increases in lower limb strength and mobility,33 which can help elderly people maintain functional and weekly physical activity levels. These results appear to be mediated by a cognitive and vascular reserve. While cognitive reserve represents the efficiency of the damaged brain in maintaining its cognitive and functional capacity, through a compensation mechanism in its neural networks,34 vascular reserve is a specific competence of cerebral blood vessels to respond to increased metabolic demand and chemical, mechanical, or neural stimuli.35 Both abilities are dependent on the habits acquired by the individual during life and involve several mechanisms, such as cerebral blood flow, bioavailability of nitric oxide, production of reactive oxygen species (ROS) and trophic factors such as Brain-Derived Neurotrophic Factor (BDNF), Vascular Endothelial Growth Factor (VEGF) and Insulin-Like Growth Factor (IGF-1).36 However, during the course of aging, these systems are impaired, which tends to hinder these adaptive responses of the cerebral and vascular reserve.35 One of the physiological changes promoted by the increase in aerobic capacity is increased blood flow, not only peripheral but central, where this cardiovascular adjustment culminates in the regulation of the endothelial expression of nitric oxide, which in turn, performs BDNF and VEGF signalling.35 Other biochemical pathways involving ROS, trophic factors, and anti-inflammatory cytokines are also suggested as modulators of neuroplasticity induced by aerobic capacity and physical exercise.37,38 The present study has some limitations that must be considered, such as the small sample size and the estimated protocol used to assess VO2max. Moreover, there was no difference in the physical activity levels (measured by IPAQ) among groups. Although IPAQ is widely used and well validated, there are several limitations inherent to this questionnaire. Studies have reported a poor correlation between IPAQ and number of steps (measured by accelerometer) and also IPAQ overestimates physical activity in some populations.39,40 It is important to highlight that, in studies with dementia patients, the questionnaire is answered by the caregiver, which may contribute to some inconsistencies in the final score of the test. The cross-sectional design of the study precludes the establishment of a cause-effect relationship. Patients with MCI and AD may be more sedentary than healthy elderly due a decrease in the IADLs levels and leisure-time activities, but this sedentary behavior can also contribute to higher risk and low aerobic capacity in these individuals. In addition, information is lacking on the reliability and typical errors of the Step test in this specific population. However, unlike previous studies, the use of the STEP test allowed us to evaluate the aerobic capacity associated with the levels of physical independence and to understand how they may be related to the diagnosis of dementia. Furthermore, the STEP test is a simple and ecological evaluation, which facilitates the extension of these results for clinical use. Therefore, in community-dwelling elderly, aerobic capacity measured using the STEP test is positively correlated with overall cognition and associated with reduced risk of being diagnosed with MCI or AD. The evaluation of elderly aerobic capacity can contribute to the development of strategies to prevent dementia. Elderly people should be encouraged to practice physical exercises, mainly aerobic and multimodal, to help maintain cardiorespiratory levels above the functional risk score. This study was conducted at the Institute of Psychiatry, Federal University of Rio de Janeiro (UFRJ), RJ, Brazil. Acknowledgment. We thank the following funding agencies: the Conselho Nacional de Desenvolvimento Cientifico e Tecnológico (CNPq-301483/2016-7), Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) and Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ-E26/203.193/2016). REFERENCES 1 1 Fleg JL, Morrell CH, Bos AG, Brant LJ, Talbot LA, Wright JG, et al. Accelerated longitudinal decline of aerobic capacity in healthy older adults. Circulation. 2005;112(5):674-82. Fleg JL Morrell CH Bos AG Brant LJ Talbot LA Wright JG Accelerated longitudinal decline of aerobic capacity in healthy older adults Circulation 2005 112 5 674 682 2 2 Forman DE, Arena R, Boxer R, Dolansky MA, Eng JJ, Fleg JL, et al. Prioritizing functional capacity as a principal end point for therapies oriented to older adults with cardiovascular disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2017;135(16):e894-e918. Forman DE Arena R Boxer R Dolansky MA Eng JJ Fleg JL Prioritizing functional capacity as a principal end point for therapies oriented to older adults with cardiovascular disease: a scientific statement for healthcare professionals from the American Heart Association Circulation 2017 135 16 e894 e918 3 3 Wendell CR, Gunstad J, Waldstein SR, Wright JG, Ferrucci L, Zonderman AB. Cardiorespiratory fitness and accelerated cognitive decline with aging. J Gerontol A Biol Sci Med Sci. 2013;69(4):455-62. Wendell CR Gunstad J Waldstein SR Wright JG Ferrucci L Zonderman AB Cardiorespiratory fitness and accelerated cognitive decline with aging J Gerontol A Biol Sci Med Sci 2013 69 4 455 462 4 4 Zhu W, Hooker SP, Sun Y, Xie M, Su H, Cao J. Associations of cardiorespiratory fitness with cardiovascular disease risk factors in middle-aged Chinese women: a cross-sectional study. BMC women's health. 2014;14(1):62. Zhu W Hooker SP Sun Y Xie M Su H Cao J Associations of cardiorespiratory fitness with cardiovascular disease risk factors in middle-aged Chinese women: a cross-sectional study BMC women's health 2014 14 1 62 62 5 5 DeFina LF, Willis BL, Radford NB, Gao A, Leonard D, Haskell WL, et al. The Association Between Midlife Cardiorespiratory Fitness Levels and Later-Life Dementia: a Cohort Study. Ann Intern Med. 2013;158(3):162-8. DeFina LF Willis BL Radford NB Gao A Leonard D Haskell WL The Association Between Midlife Cardiorespiratory Fitness Levels and Later-Life Dementia: a Cohort Study Ann Intern Med 2013 158 3 162 168 6 6 Prince M, Wimo A, Guerchet M, Ali G, Wu Y, Prina M. World Alzheimer Report 2015. The Global Impact of Dementia. Alzheimer's Disease International. Alzheimer's Disease International (ADI), London; 2015. Prince M Wimo A Guerchet M Ali G Wu Y Prina M World Alzheimer Report 2015. The Global Impact of Dementia. Alzheimer's Disease International Alzheimer's Disease International London 2015 7 7 Iachini I, Iavarone A, Senese VP, Ruotolo F, Ruggiero G. Visuospatial memory in healthy elderly, AD and MCI: a review. Curr Aging Sci. 2009;2(1):43-59. Iachini I Iavarone A Senese VP Ruotolo F Ruggiero G Visuospatial memory in healthy elderly, AD and MCI: a review Curr Aging Sci 2009 2 1 43 59 8 8 Petersen R. Normal aging, mild cognitive impairment, and early Alzheimer's disease. Neurologist. 1995;1:326-44. Petersen R Normal aging, mild cognitive impairment, and early Alzheimer's disease Neurologist 1995 1 326 344 9 9 Roberts R, Knopman DS. Classification and epidemiology of MCI. Clin Geriatr Med. 2013;29(4):753-72. Roberts R Knopman DS Classification and epidemiology of MCI Clin Geriatr Med 2013 29 4 753 772 10 10 Müller J, Chan K, Myers JN. Association Between Exercise Capacity and Late Onset of Dementia, Alzheimer Disease, and Cognitive Impairment. Mayo Clin Proc. 2017;92(2):211-217. Müller J Chan K Myers JN Association Between Exercise Capacity and Late Onset of Dementia, Alzheimer Disease, and Cognitive Impairment Mayo Clin Proc 2017 92 2 211 217 11 11 Rikli RE, Jones CJ. Development and validation of a functional fitness test for community-residing older adults. J Aging Phys Act. 1999;7(2): 129-61. Rikli RE Jones CJ Development and validation of a functional fitness test for community-residing older adults J Aging Phys Act 1999 7 2 129 161 12 12 Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303-8. Petersen RC Smith GE Waring SC Ivnik RJ Tangalos EG Kokmen E Mild cognitive impairment: clinical characterization and outcome Arch Neurol 1999 56 3 303 308 13 13 Medicine ACoS. Manual do ACSM para teste de esforço e prescrição de exercício. Tradução: Paula Chermont P Estima 5ª ed Rio de Janeiro: Revinter; 2000. Medicine ACoS Manual do ACSM para teste de esforço e prescrição de exercício Estima Paula Chermont P 5ª ed Rio de Janeiro Revinter 2000 14 14 Zanco MF, Moraes H, Maranhão Neto G, Laks J, Deslandes AC. Assessing cardiorespiratory capacity in older adults with major depression and Alzheimer disease. J Bras Psiquiatr. 2016;65(1):1-8. Zanco MF Moraes H Maranhão G Neto Laks J Deslandes AC Assessing cardiorespiratory capacity in older adults with major depression and Alzheimer disease J Bras Psiquiatr 2016 65 1 1 8 15 15 Burns JM, Cronk BB, Anderson HS, Donnelly JE, Thomas GP, Harsha A, et al. Cardiorespiratory fitness and brain atrophy in early Alzheimer disease. Neurology. 2008;71(3):210-6. Burns JM Cronk BB Anderson HS Donnelly JE Thomas GP Harsha A Cardiorespiratory fitness and brain atrophy in early Alzheimer disease Neurology 2008 71 3 210 216 16 16 Kato E, Radanovic M, Smid J, Caramelli P, Brucki S, Nitrini R. Evaluation of the balance control in Alzheimer disease. Arq Neuropsiquiatr. 2005;63(2):S110. Kato E Radanovic M Smid J Caramelli P Brucki S Nitrini R Evaluation of the balance control in Alzheimer disease Arq Neuropsiquiatr 2005 63 2 S110 S110 17 17 Zidan M, Arcoverde C, Araújo NBd, Vasques P, Rios A, Laks J, et al. Alterações motoras e funcionais em diferentes estágios da doença de Alzheimer. Rev Psiquiatr Clín. 2012;39(5):161-5. Zidan M Arcoverde C Araújo NBd Vasques P Rios A Laks J Alterações motoras e funcionais em diferentes estágios da doença de Alzheimer Rev Psiquiatr Clín 2012 39 5 161 165 18 18 Barnes DE, Yaffe K, Satariano WA, Tager IB. A longitudinal study of cardiorespiratory fitness and cognitive function in healthy older adults. J Am Geriatr Soc. 2003;51(4):459-65. Barnes DE Yaffe K Satariano WA Tager IB A longitudinal study of cardiorespiratory fitness and cognitive function in healthy older adults J Am Geriatr Soc 2003 51 4 459 465 19 19 Voss MW, Weng TB, Burzynska AZ, Wong CN, Cooke GE, Clark R, et al. Fitness, but not physical activity, is related to functional integrity of brain networks associated with aging. NeuroImage. 2016;131:113-25. Voss MW Weng TB Burzynska AZ Wong CN Cooke GE Clark R Fitness, but not physical activity, is related to functional integrity of brain networks associated with aging NeuroImage 2016 131 113 125 20 20 Schultz SA, Boots EA, Darst BF, Zetterberg H, Blennow K, Edwards DF, et al. Cardiorespiratory fitness alters the influence of a polygenic risk score on biomarkers of AD. Neurology. 2017;88(17):1650-8. Schultz SA Boots EA Darst BF Zetterberg H Blennow K Edwards DF Cardiorespiratory fitness alters the influence of a polygenic risk score on biomarkers of AD Neurology 2017 88 17 1650 1658 21 21 Dougherty RJ, Schultz SA, Boots EA, Ellingson LD, Meyer JD, Van Riper S, et al. Relationships between cardiorespiratory fitness, hippocampal volume, and episodic memory in a population at risk for Alzheimer's disease. Brain Behav. 2017;7(3):e00625. Dougherty RJ Schultz SA Boots EA Ellingson LD Meyer JD Van Riper S Relationships between cardiorespiratory fitness, hippocampal volume, and episodic memory in a population at risk for Alzheimer's disease Brain Behav 2017 7 3 e00625 22 22 Teixeira CVL, Rezende TJ, Weiler M, Nogueira MH, Campos BM, Pegoraro LF, et al. Relation between aerobic fitness and brain structures in amnestic mild cognitive impairment elderly. Age (Dordr). 2016;38(3):51. Teixeira CVL Rezende TJ Weiler M Nogueira MH Campos BM Pegoraro LF Relation between aerobic fitness and brain structures in amnestic mild cognitive impairment elderly Age (Dordr) 2016 38 3 51 51 23 23 Ding K, Tarumi T, C Zhu D, Tseng B, P Thomas B, Turner M, et al. Cardiorespiratory Fitness and White Matter Neuronal Fiber Integrity in Mild Cognitive Impairment. J Alzheimers Dis. 2018;61(2):729-39. Ding K Tarumi T C Zhu D Tseng B P Thomas B Turner M Cardiorespiratory Fitness and White Matter Neuronal Fiber Integrity in Mild Cognitive Impairment J Alzheimers Dis 2018 61 2 729 739 24 24 Brown AD, McMorris CA, Longman RS, Leigh R, Hill MD, Friedenreich CM, et al. Effects of cardiorespiratory fitness and cerebral blood flow on cognitive outcomes in older women. Neurobiol Aging. 2010; 31(12):2047-57. Brown AD McMorris CA Longman RS Leigh R Hill MD Friedenreich CM Effects of cardiorespiratory fitness and cerebral blood flow on cognitive outcomes in older women Neurobiol Aging 2010 31 12 2047 2057 25 25 Bouchard C, Sarzynski MA, Rice TK, Kraus WE, Church TS, Sung YJ, et al. Genomic predictors of the maximal O2 uptake response to standardized exercise training programs. J Appl Physiol. 2010;110(5):1160-70. Bouchard C Sarzynski MA Rice TK Kraus WE Church TS Sung YJ Genomic predictors of the maximal O2 uptake response to standardized exercise training programs J Appl Physiol 2010 110 5 1160 1170 26 26 Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, McTiernan A, et al. Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch Neurol. 2010;67(1):71-9. Baker LD Frank LL Foster-Schubert K Green PS Wilkinson CW McTiernan A Effects of aerobic exercise on mild cognitive impairment: a controlled trial Arch Neurol 2010 67 1 71 79 27 27 Smith JC, Nielson KA, Antuono P, Lyons J-A, Hanson RJ, Butts AM, et al. Semantic memory functional MRI and cognitive function after exercise intervention in mild cognitive impairment. J Alzheimers Dis. 2013;37(1):197-215. Smith JC Nielson KA Antuono P Lyons J-A Hanson RJ Butts AM Semantic memory functional MRI and cognitive function after exercise intervention in mild cognitive impairment J Alzheimers Dis 2013 37 1 197 215 28 28 Salisbury D. Enhanced cardiovascular fitness attenuates cognitive decline in Alzheimer's disease. Innov Aging. 2017;1(suppl 1):347-8. Salisbury D Enhanced cardiovascular fitness attenuates cognitive decline in Alzheimer's disease Innov Aging 2017 1 suppl 1 347 348 29 29 Reiter K, Nielson KA, Smith TJ, Weiss LR, Alfini AJ, Smith JC. Improved cardiorespiratory fitness is associated with increased cortical thickness in mild cognitive impairment. J Int Neuropsychol Soci. 2015;21(10):757-67. Reiter K Nielson KA Smith TJ Weiss LR Alfini AJ Smith JC Improved cardiorespiratory fitness is associated with increased cortical thickness in mild cognitive impairment J Int Neuropsychol Soci 2015 21 10 757 767 30 30 Köbe T, Witte AV, Schnelle A, Lesemann A, Fabian S, Tesky VA, et al. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment. NeuroImage. 2016;131:226-38. Köbe T Witte AV Schnelle A Lesemann A Fabian S Tesky VA Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment NeuroImage 2016 131 226 238 31 31 Sampaio A, Marques EA, Mota J, Carvalho J. Effects of a multicomponent exercise program in institutionalized elders with Alzheimer's disease. Dementia. 2016. DOI: 10.1177/1471301216674558 Sampaio A Marques EA Mota J Carvalho J Effects of a multicomponent exercise program in institutionalized elders with Alzheimer's disease Dementia 2016 10.1177/1471301216674558 32 32 Ozaki H, Loenneke JP, Thiebaud RS, Abe T. Resistance training induced increase in VO 2 max in young and older subjects. Eur Rev Aging Phys Act. 2013;10(2):107. Ozaki H Loenneke JP Thiebaud RS Abe T Resistance training induced increase in VO 2 max in young and older subjects Eur Rev Aging Phys Act 2013 10 2 107 107 33 33 Krist L, Dimeo F, Keil T. Can progressive resistance training twice a week improve mobility, muscle strength, and quality of life in very elderly nursing-home residents with impaired mobility? A pilot study. Clin Interv Aging. 2013;8:443-8. Krist L Dimeo F Keil T Can progressive resistance training twice a week improve mobility, muscle strength, and quality of life in very elderly nursing-home residents with impaired mobility? A pilot study Clin Interv Aging 2013 8 443 448 34 34 Stern Y. Cognitive reserve. Neuropsychologia. 2009;47(10):2015-28. Stern Y Cognitive reserve Neuropsychologia 2009 47 10 2015 2028 35 35 Davenport MH, Hogan DB, Eskes GA, Longman RS, Poulin MJ. Cerebrovascular reserve: the link between fitness and cognitive function? Exerc Sport Sci Rev. 2012;40(3):153-8. Davenport MH Hogan DB Eskes GA Longman RS Poulin MJ Cerebrovascular reserve: the link between fitness and cognitive function? Exerc Sport Sci Rev 2012 40 3 153 158 36 36 Nithianantharajah J, Hannan AJ. The neurobiology of brain and cognitive reserve: mental and physical activity as modulators of brain disorders. Prog Neurobiol. 2009;89(4):369-82. Nithianantharajah J Hannan AJ The neurobiology of brain and cognitive reserve: mental and physical activity as modulators of brain disorders Prog Neurobiol 2009 89 4 369 382 37 37 Hayes SM, Hayes JP, Cadden M, Verfaellie M. A review of cardiorespiratory fitness-related neuroplasticity in the aging brain. Front Aging Neurosci. 2013;5:31. Hayes SM Hayes JP Cadden M Verfaellie M A review of cardiorespiratory fitness-related neuroplasticity in the aging brain Front Aging Neurosci 2013 5 31 31 38 38 Radak Z, Zhao Z, Koltai E, Ohno H, Atalay M. Oxygen consumption and usage during physical exercise: the balance between oxidative stress and ROS-dependent adaptive signaling. Antioxid Redox Signal. 2013;18(10):1208-46. Radak Z Zhao Z Koltai E Ohno H Atalay M Oxygen consumption and usage during physical exercise: the balance between oxidative stress and ROS-dependent adaptive signaling Antioxid Redox Signal 2013 18 10 1208 1246 39 39 Craig CL, Marshall AL, Sjorstrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381-95. Craig CL Marshall AL Sjorstrom M Bauman AE Booth ML Ainsworth BE International physical activity questionnaire: 12-country reliability and validity Med Sci Sports Exerc 2003 35 8 1381 1395 40 40 Brown W, Bauman A, Chey T, Trost S, Mummery K. Comparison of surveys used to measure physical activity. Aust N Z J Public Health. 2004;28(2):128-34. Brown W Bauman A Chey T Trost S Mummery K Comparison of surveys used to measure physical activity Aust N Z J Public Health 2004 28 2 128 134